[The effect of hepatoprotectors on lipid metabolism in CCl4-hepatitis].
The hepatoprotective agents, silybinin and essentiale, were shown to prevent the development of lipid metabolism disturbances in the liver and serum of rats with CCl4-hepatitis. Slow accumulation of triglycerides, lysophosphatidylcholine and cardiolipin was observed in animals treated with these drugs, while phosphatidylcholine liver level remained high. Silybinin and essentiale inhibited the production of lipid hydroperoxide, Shiff basis, malonic dialdehyde, intensified the function of tissue antioxidants, activated liver beta-hydroxybutyrate dehydrogenase and depressed the activation of serum phospholipase A.
D000818:Animals; D002252:Carbon Tetrachloride Poisoning / Q000378:metabolism* / Q000517:prevention & control; D056486:Chemical and Drug Induced Liver Injury / Q000378:metabolism* / Q000517:prevention & control; D005419:Flavonoids / Q000494:pharmacology*; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008099:Liver / Q000378:metabolism; D008297:Male; D010713:Phosphatidylcholines / Q000494:pharmacology*; D010743:Phospholipids / Q000097:blood / Q000378:metabolism; D051381:Rats; D012838:Silymarin / Q000494:pharmacology*
D005419:Flavonoids; D008055:Lipids; D010713:Phosphatidylcholines; D010743:Phospholipids; D012838:Silymarin; C011246:essential 303 forte
Vliianie gepatoprotektorov na metabolizm lipidov pri CCl4-gepatite.